Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-003802
Filing Date
2021-03-30
Accepted
2021-03-30 11:30:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27658
2 filename2.txt TEXT-EXTRACT 1491
  Complete submission text file 0000000000-21-003802.txt   40380
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filed for) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations